ABN AMRO Bank N.V. acquired a new stake in The Allstate Corporation (NYSE:ALL - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 19,510 shares of the insurance provider's stock, valued at approximately $4,694,000.
Several other large investors also recently modified their holdings of the business. Kelleher Financial Advisors acquired a new stake in Allstate during the 2nd quarter valued at approximately $28,000. GSA Capital Partners LLP acquired a new position in shares of Allstate in the 2nd quarter valued at approximately $2,782,000. Pacific Sage Partners LLC purchased a new position in shares of Allstate during the 2nd quarter valued at approximately $242,000. One Wealth Advisors LLC acquired a new stake in shares of Allstate during the second quarter worth approximately $355,000. Finally, Clearstead Trust LLC acquired a new stake in shares of Allstate during the second quarter worth approximately $36,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other Allstate news, COO Mario Rizzo sold 56,225 shares of the company's stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $264.48, for a total value of $14,870,388.00. Following the completion of the transaction, the chief operating officer owned 82,227 shares in the company, valued at approximately $21,747,396.96. This represents a 40.61% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Andrea Redmond sold 2,225 shares of the firm's stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $202.91, for a total transaction of $451,474.75. Following the completion of the sale, the director owned 2,225 shares in the company, valued at $451,474.75. The trade was a 50.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 92,996 shares of company stock valued at $24,543,894. 1.55% of the stock is owned by company insiders.
Allstate Price Performance
Shares of ALL opened at $261.26 on Friday. The company has a market cap of $66.06 billion, a P/E ratio of 5.22, a PEG ratio of 0.41 and a beta of 0.16. The stock has a fifty day moving average price of $246.52 and a 200 day moving average price of $222.83. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.36 and a quick ratio of 0.36. The Allstate Corporation has a 12 month low of $188.08 and a 12 month high of $277.22.
Allstate (NYSE:ALL - Get Free Report) last posted its earnings results on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.06 by $2.93. Allstate had a return on equity of 41.64% and a net margin of 18.97%.The company had revenue of $15.43 billion for the quarter, compared to analysts' expectations of $15.46 billion. During the same period last year, the business posted $5.94 earnings per share. The firm's quarterly revenue was up 11.8% compared to the same quarter last year. On average, research analysts forecast that The Allstate Corporation will post 33.92 earnings per share for the current year.
Allstate Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Monday, August 31st will be issued a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Monday, August 31st. Allstate's dividend payout ratio (DPR) is 8.63%.
Wall Street Analyst Weigh In
Several analysts recently issued reports on ALL shares. Atlantic Securities set a $319.00 price target on shares of Allstate in a report on Wednesday, July 15th. Weiss Ratings raised shares of Allstate from a "buy (a-)" rating to a "buy (a)" rating in a report on Thursday, August 6th. Barclays boosted their target price on shares of Allstate from $213.00 to $226.00 and gave the stock an "underweight" rating in a research report on Thursday, August 6th. The Goldman Sachs Group restated a "neutral" rating and issued a $280.00 target price on shares of Allstate in a research note on Friday, August 7th. Finally, Morgan Stanley set a $265.00 price target on shares of Allstate in a research report on Tuesday. Three equities research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, ten have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, Allstate currently has an average rating of "Hold" and an average target price of $265.53.
Get Our Latest Stock Report on Allstate
Trending Headlines about Allstate
Here are the key news stories impacting Allstate this week:
- Positive Sentiment: Analyst earnings estimates were raised. Dowling & Partners increased its FY2026 EPS estimate for Allstate to $35.50 from $30.50, reinforcing expectations for continued profitability. FY2026 EPS estimates article
- Positive Sentiment: JPMorgan reportedly expects further upside. The analyst maintained an overweight rating and raised its price target to $292 from $282, supporting the bullish case following Allstate’s recent earnings beat. JPMorgan analyst article
- Positive Sentiment: Allstate is investing in quantum computing. CEO Tom Wilson said the insurer plans to expand its current 10-person quantum team so it can build expertise and potentially gain a competitive advantage as the technology matures. The investment is strategically positive, although financial benefits are likely long term. Allstate quantum computing article
- Positive Sentiment: Claims operations are receiving additional investment. Allstate opened a 33,000-square-foot training campus in Dallas for its 23,000 claims professionals. Improved claims accuracy and customer service could support retention and operating efficiency. Allstate Claims University announcement
- Neutral Sentiment: Recent earnings remain a major backdrop. Allstate’s latest quarter produced $8.99 in EPS versus the $6.06 consensus estimate, while revenue rose 11.8% year over year to $15.43 billion. However, the stock is trading near its 52-week high, increasing sensitivity to any signs that profitability may moderate.
- Negative Sentiment: Insiders sold substantial holdings. COO Mario Rizzo sold 56,225 shares for approximately $14.9 million, reducing his direct position by 40.6%. Separate reports also disclosed a sizable sale by John Dugenske, potentially weighing on investor sentiment. Allstate insider sales article
- Negative Sentiment: Allstate lost an Ontario coverage challenge. Definity prevailed in court over Allstate’s excluded-driver coverage position, creating a potential legal and claims-related concern in the Canadian market. Ontario court coverage challenge article
- Negative Sentiment: Valuation concerns remain. One analysis argues Allstate’s share price assumes a 94.1% combined ratio that the company has never sustained, raising questions about whether its recent operating returns can persist.
About Allstate
(
Free Report)
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.